Serving a Broad Range of Species

Our products will serve companion animals and
production animals with prescription
and non-prescription products globally.
Neonorm Calf Available Now

Access to Powerful, Natural Compounds

Jaguar maintains an exclusive, worldwide
license to a large medicinal plant library for
veterinary applications.

Neonorm Calf Available Now

Committed to Animal Health

We are focused on the development &
commercialization of animal health
solutions that are naturally derived
& sustainably harvested.

Neonorm Calf Available Now

2014 Product Launch

We launched our first
product for use in dairy
calves in late 2014.

Neonorm Calf Available Now

A recently published university study supports the effectiveness of Neonorm™ Calf in promoting normal manure formation and reducing fluid loss in preweaned calves. It works by normalizing water flow, helping preweaned calves rebound quickly, and supports weight gain. Get your calves back to normal. Learn more at the Wisconsin Veterinary Medical Association, booth 209, from October 8th – 11th. Read the Cornell abstract here.

Naturally derived health solutions for animals around the world

We’re focused on developing and commercializing a range of first-in-class prescription and non-prescription gastrointestinal products for companion and production animals.

Jaguar is committed to identifying animal health market opportunities where we can develop species-specific products that leverage our broad intellectual property portfolio, deep pipeline and extensive botanical library.

Sept 28, 2015: Jaguar Animal Health Signs Crofelemer Manufacturing & Supply Agreement with Glenmark Pharmaceuticals Ltd.
Sep 25, 2015: Jaguar Animal Health Initiates Proof-of-Concept Study to Evaluate Safety, Tolerability & Efficacy of Neonorm in Foals
Sept 2, 2015: Study Evaluating Effect of Jaguar Animal Health’s Neonorm on Diarrhea in Newborn Dairy Calves Published in Journal of Dairy Science  

Would you like to receive occasional updates about Jaguar and our products? If so, enter your email address to join our mailing list: